Seqirus Inc., Summit, New Jersey, has been awarded an estimated $24,080,075 firm-fixed-price, indefinite-quantity contract for injectable influenza vaccines. This was a competitive acquisition with four responses received. This is a one-year contract with no option periods. The ordering period end date is March 12, 2025. Using customers are Army, Air Force, Navy, Marine Corps, and Coast Guard. Type of appropriation is fiscal 2024 through 2025 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-24-D-0004).